Clinical Trial Update: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 study of BK1301 DTaP vaccine booster in adolescents completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• BK1301 DTaP vaccine booster (BK1301)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2016-11-21